These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32080808)

  • 21. Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy.
    Hulshoff JB; Faiz Z; Karrenbeld A; Kats-Ugurlu G; Burgerhof JG; Smit JK; Plukker JT
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1301-9. PubMed ID: 26314875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of recurrence pattern in locally advanced esophageal squamous cell carcinoma: Results from the phase III trial NEOCRTEC5010.
    Chen D; Kong M; Sun J; Yang H; Chen Y; Fang W; Yu Z; Mao W; Xiang J; Han Y; Chen Z; Yang H; Wang J; Pang Q; Zheng X; Yang H; Li T; Zhang X; Li Q; Wang G; Mao T; Guo X; Lin T; Liu M; Witharana P; Fu J; Chen B; Shen J; Zhu C
    J Thorac Cardiovasc Surg; 2023 Mar; 165(3):888-897. PubMed ID: 36137841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Significance of
    Hamai Y; Hihara J; Emi M; Ibuki Y; Murakami Y; Nishibuchi I; Nagata Y; Aoki Y; Furukawa T; Okada M
    Ann Surg Oncol; 2019 Jun; 26(6):1869-1878. PubMed ID: 30675704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic histological factors in patients with esophageal squamous cell carcinoma after preoperative chemoradiation followed by surgery.
    Tu CC; Hsu PK; Chien LI; Liu WC; Huang CS; Hsieh CC; Hsu HS; Wu YC
    BMC Cancer; 2017 Jan; 17(1):62. PubMed ID: 28103913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymph node volume predicts survival in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery.
    Pao TH; Chen YY; Chang WL; Wu SY; Lai WW; Tseng YL; Chung TJ; Lin FC
    PLoS One; 2024; 19(3):e0300173. PubMed ID: 38547184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival impact of the number of lymph nodes dissection in patients receiving neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
    Jiang D; Liu XB; Xing WQ; Chen PN; Feng SK; Yan S; Lerut T; Sun HB
    Dis Esophagus; 2023 Apr; 36(5):. PubMed ID: 36385581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of pathological tumor response and residual nodal metastasis in patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery.
    Oguma J; Ozawa S; Koyanagi K; Kazuno A; Yamamoto M; Ninomiya Y; Yatabe K
    Esophagus; 2019 Oct; 16(4):395-401. PubMed ID: 31190104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival Impact of Total Resected Lymph Nodes in Esophageal Cancer Patients With and Without Neoadjuvant Chemoradiation.
    Ho HJ; Chen HS; Hung WH; Hsu PK; Wu SC; Chen HC; Wang BY
    Ann Surg Oncol; 2018 Dec; 25(13):3820-3832. PubMed ID: 30284131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Completely Resectable (cT1-2) Esophageal Squamous Cell Carcinoma with Minimal Lymph Node Involvement (cN1): Is Neoadjuvant Chemoradiation Therapy the Only Viable Treatment Option?
    Yang YH; Park BJ; Kim HE; Kim H; Kim DJ
    Ann Surg Oncol; 2024 Apr; 31(4):2490-2498. PubMed ID: 38153644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of the circumferential resection margin and its definitions in esophageal cancer patients after neoadjuvant chemoradiotherapy.
    Depypere L; Moons J; Lerut T; De Hertogh G; Peters C; Sagaert X; Coosemans W; Van Veer H; Nafteux P
    Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29036407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Comparison of Clinicopathologic Outcomes and Patterns of Lymphatic Spread Across Neoadjuvant Chemotherapy, Neoadjuvant Chemoradiotherapy, and Neoadjuvant Immunochemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma.
    Tian Y; Shi Z; Wang C; Ke S; Qiu H; Zhao W; Wu Y; Chen J; Zhang Y; Chen Y
    Ann Surg Oncol; 2024 Feb; 31(2):860-871. PubMed ID: 37947979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perineural invasion through the sheath in posttherapy esophagectomy specimens predicts poor survival in patients with esophageal squamous cell carcinoma.
    Tsai CY; Yeh CJ; Chao YK; Chang HK; Tseng CK; Liu YH
    Eur J Surg Oncol; 2017 Oct; 43(10):1970-1976. PubMed ID: 28801062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors Affecting Survival in Operated Esophageal Squamous Cell Carcinoma.
    Akgul N; Sakin A; Sahin S; Aldemir MN; Aytekin A; Alay M; Iliklerden UH; Kotan MC
    J Gastrointest Cancer; 2022 Jun; 53(2):439-445. PubMed ID: 33788157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic impact of sterilized lymph nodes in esophageal squamous cell carcinomas after neoadjuvant chemoradiotherapy.
    Zhong J; Wang K; Fang S; Fu J
    Eur J Surg Oncol; 2021 Dec; 47(12):3074-3080. PubMed ID: 34023168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
    Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
    Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.
    Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z
    BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reliability of clinical nodal status regarding response to neoadjuvant chemoradiotherapy compared with surgery alone and prognosis in esophageal cancer patients.
    Dijksterhuis WPM; Hulshoff JB; van Dullemen HM; Kats-Ugurlu G; Burgerhof JGM; Korteweg T; Mul VEM; Hospers GAP; Plukker JTM
    Acta Oncol; 2019 Nov; 58(11):1640-1647. PubMed ID: 31397195
    [No Abstract]   [Full Text] [Related]  

  • 38. Association between the thoroughness of the histopathological examination and survival in patients with esophageal squamous cell carcinoma who achieve pathological complete response after chemoradiotherapy.
    Chiu CH; Chen WH; Wen YW; Yeh CJ; Chao YK; Chang HK; Tseng CK; Liu YH
    Dis Esophagus; 2016 Aug; 29(6):634-41. PubMed ID: 26175202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pT2 Adenocarcinoma of the esophagus: early or advanced cancer?
    Metzger R; Lorenz D; Gockel I; Origer J; Plum PS; Junginger T; Drebber U; Hansen T; Krümpelmann K; Fisseler-Eckhoff A; Lang H; Hölscher AH; Bollschweiler E
    Ann Thorac Surg; 2013 Nov; 96(5):1840-5. PubMed ID: 23987902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery in patients with locally advanced esophageal squamous cell carcinoma who achieved clinical complete response when induction chemoradiation finished: A phase II random.
    Qian D; Chen X; Shang X; Wang Y; Tang P; Han D; Jiang H; Chen C; Zhao G; Zhou D; Cao F; Er P; Zhang W; Li X; Zhang T; Zhang B; Guan Y; Wang J; Yuan Z; Yu Z; Wang P; Pang Q
    Radiother Oncol; 2022 Sep; 174():1-7. PubMed ID: 35764191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.